40th Congress of the Société Internationale d'Urologie

SIU
America/New York GMT -4 summer

Description

0230-0250

 

JS-02: Joint SIU-International Continence Society (ICS) Session

 

Co-Chairs: David Castro-Díaz, Spain / Stavros Charalampous, Cyprus

 

0230-0240

Update on Intrinsic Sphincter Dysfunction in Women

Helen O'Connell, Australia

 

0240-0250

ELUTS in the Elderly: Are We Dealing with DOA or DU?

Adrian Wagg, Canada

 

0300-0400

 

SYMP-07: Indian Urology Symposium

 

Chair: Rajeev TP, India

Moderators: Madhu S Agrawal, India / Kim Mammen, India

 

0300-0300

Bipolar Enucleation – An Ideal Modality in Very Large Prostates

Chiruvella Mallikarjuna, India

 

0305-0310

Is Serum PSA Still a Standard Marker for PCa: Do We Have Game Changers?

Anant Kumar, India

 

0310-0315

Advantages and Limitations of PSMA – PET

Rajeev Sood, India

 

0315-0320

Role of Systemic Therapy in Metastatic RCC

Sudhir Rawal, India

 

0320-0325

How to Obtain a Good Percutaneous Access – Points to Consider

Ravindra Sabnis, India

 

0325-0330

Radiation Exposure During PCNL and Methods to Circumvent this Hazard

Rajeev TP, India

 

0300-0400

 

MC-04: Master Class 04 - Establishing Standardized Outcome Reporting in Your Urology Practice

 

Co-Chairs: Matthew Cooperberg, United States / Ghulam Nabi, United Kingdom

 

 

Learning Objectives:

 

• Describe various components of high-quality urologic care, in terms of both processes and outcomes

• Identify existing and emerging data registries to facilitate reporting of outcomes for urologic care

• Plan for eventual mandated and/or public reporting of quality of care data

• Assess and appraise existing literature in their area of urological conditions care

 

Methods to promote active learning

 

• Discussions including question/answer

• Informal and formal feedback through follow-up email addresses made available to delegates at the end of lectures.

 

 

 

0300-0305

Introduction

Ghulam Nabi, United Kingdom

 

0305-0315

Standardizing Data Reporting in Urology: The AUA Quality (AQUA) Registry

Matthew Cooperberg, United States

 

0315-0325

To Measure is to Improve

Sigrid V. Carlsson, United States

 

0325-0335

Do The Numbers Tell The Tale?

Monique J. Roobol, The Netherlands

 

0335-0345

Standardising Outcome Reporting in Urological Complications

Faculty: Chandra Shekhar Biyani, United Kingdom

 

0345-0355

Outcome Reporting in Renal Cancer: Progress and Future

Faculty: Faiz Mumtaz, United Kingdom

 

0355-0400

Take Home Messages and Conclusions

Matthew Cooperberg, United States

Ghulam Nabi, United Kingdom

 

0400-0420

 

JS-03: SIU-Society of Urologic Oncology (SUO)/EAU Section of Oncological Urology (ESOU) Session

 

Co-Chairs: Christopher Evans, United States / Morgan Roupret, France

 

 

Learning Objectives

 

Identify the surgical approach, morbidity and outcomes of radical cystectomy in locally advanced disease

Understand indications, response rates and toxicities of chemotherapy and immunotherapy in urothelial cancer

Identify the pros and cons of nephron sparing surgery in stage T2 renal cell carcinoma

Discuss the management options, risks and benefits of therapeutic approaches (Kidney sparing surgery vs. radical NU) for upper tract urothelial carcinoma

Understand the relevant germline and somatic mutations in patients with advanced prostate cancer and the therapeutic implications

 

0400-0410

Germline and Somatic Mutations in Advanced Prostate Cancer; Actionable Targets

Christopher Evans, United States

 

0410-0420

Management of Invasive Upper Urinary Tract Urothelial Carcinoma

Morgan Roupret, France

 

0400-0500

 

CO-02: Controversies in Urology 02 - Controversies in the Management of Kidney Cancer

 

Co-Chairs: Surena Matin, United States / Amlesh Seth, India

 

 

At the end of this session, attendees will be able to:

 

Understand metastatic kidney cancer is not a single disease with uniform prognosis and understand the need for individually tailored management strategies.

Understand the advantages and disadvantages of cytoreductive nephrectomy (CN), along with the indications, timing and integration of CN with systemic therapy.

Debate the advantages and disadvantages of open vs. robotic partial nephrectomy and know how to select the right approach for the right patient in the right setting.

Understand the nuances of practically managing localized and metastatic kidney cancer.

Methods: Case presentations and debate

 

0400-0420

Debate: Is There Still a Role for Cytoreductive Nephrectomy in the Management of Kidney Cancer?

 

0400-0415

Against

Axel Bex, The Netherlands

 

0415-0430

For

Jose Karam, United States

 

0430-0440

Debate Summary

Surena Matin, United States

 

0440-0455

Controversies in the Management of Small Renal Masses

Amlesh Seth, India

 

0430-0530

 

IS-02: Interactive Session 02 - Management of Penile Cancer including Organ-Sparing Approaches

 

Co-Chairs: Nicola Nicolai, Italy / Curtis Pettaway, United States

 

Learning Objectives:

 

At the end of this session, attendees will be able to:

 

Understand the importance of pathologic stage, tumor location, and histologic variables in determining treatment options for the primary tumor

Describe the different approaches to managing the primary penile tumor

Discuss the importance and options for accurately determining inguinal lymph node status among patients with invasive primary tumors and no palpable inguinal adenopath

Discuss current Multimodality treatment options among patients presenting with bulky regional adenopathy from penile cancer

Method: Panel and discussion

 

0430-0445

Case Type 1: - Primary Tumor Management - Management of Lower Risk Primary-CIS, T1a

 

Panelists

Pierre Blanchard, France

Steve Nicholson, United Kingdom

Nicola Nicolai, Italy

Curtis Pettaway, United States

Philippe Spiess, United States

 

0445-0510

Case Type 2: Management of High-Risk Primary and Clinically Negative Nodes

 

Panelists

Pierre Blanchard, France

Steve Nicholson, United Kingdom

Nicola Nicolai, Italy

Curtis Pettaway, United States

Philippe Spiess, United States

 

0510-0530

Case Type 3: Management of Bulky Inguinal Lymph Nodes at Presentation

 

Panelists

Pierre Blanchard, France

Steve Nicholson, United Kingdom

Nicola Nicolai, Italy

Curtis Pettaway, United States

Philippe Spiess, United States

 

0500-0600

 

IC-04: Instructional Course 04 - The Current Situation of Antimicrobial-Resistant Pathogens In Urological Fields

 

Co-Chairs: Satoshi Takahashi, Japan / Koichiro Wada, Japan

 

 

Learning Objectives:

 

At the end of this session, attendees will be able to:

 

Recall the current situation of antimicrobial-resistant pathogens and management for UTI caused by antimicrobial-resistant pathogens

 

 

 

0500-0515

The Current Situation of Antimicrobial-Resistant Pathogens in Urological Fields

Hiroshi Kiyota, Japan

 

0515-0525

Best Management for UTI Caused by Quinolone-Resistant Pathogens

Koichiro Wada, Japan

 

0525-0540

Best Management for UTI Caused by ESBL Producing Pathogens

Satoshi Takahashi, Japan

 

0540-0555

Best Management for Antimicrobial Prophylaxis in Prostate Biopsy

Koichiro Wada, Japan

 

0530-0630

 

IC-05: Instructional Course 05 - Metabolic Work Up and Medical Treatment of Stones

 

Chair: Mohamed El-Shazly, Egypt

 

 

Learning Objectives:

 

At the end of this session, attendees will be able to:

 

Recall the basics and practical simplified alghorithm of metabolic workup and medical treatment. This will be presented in a simplified practical way without digging into the dilemma of theories and controversies in this tough topic

Recite the updated medical treatment protocols for different types of stones

 

0530-0550

Metabolic Work Up of Stones

Mohamed El-Shazly, Egypt

 

0550-0610

Medical Treatment of Calcium Stones

Noor Buchholz, United Kingdom

 

0610-0630

Medical Treatment of Uric Acid, Cysteine and Infected (Struvite) Stones

Ahmed El-Nahas, Kuwait

 

0600-0700

 

IC-06: Instructional Course 06 - Urethral Stricture Surgery

 

Chair: Sanjay Kulkarni, India

 

 

Learning Objectives:

 

At the end of this session, attendees will be able to:

 

Determine criteria for reconstruction based on location and etiology of the stricture

Recall essential techniques for simple and complex anterior urethral reconstruction

Apply innovations in penile and bulbar urethral stricture management

Summarize preoperative and intraoperative preparation for posterior urethroplasty cases after pelvic fracture urethral injury

 

0600-0615

Penile Urethra Simple and Complex

Guido Barbagli, Italy

 

0615-0620

Discussion and Questions

Guido Barbagli, Italy

 

0620-0635

Bulbar Urethra Anastomotic, Dorsal and Ventral BMG, Non-Transection Bulbar Urethroplasty

Anthony Mundy, United Kingdom

 

0635-0640

Discussion and Questions

Anthony Mundy, United Kingdom

 

0640-0655

Posterior Urethral Injury Acute Management and Delayed Treatment, Complex PFUI

Sanjay Kulkarni, India

 

0655-0700

Discussion and Questions

Sanjay Kulkarni, India

 

0630-0650

 

JS-04: Joint SIU-Endourology Session

 

Co-Chairs: Mahesh R. Desai, India / Jorge Gutierrez, United States

To view this session in your own timezone, please click here.

 

 

Learning Objectives:

 

Learn different endoscopic surgical techniques for endourology procedures

Understand the advantages and limitations of percutaneous and ureteroscopic surgeries

Recognize the best surgical candidates for endoscopic surgery, specifically understand the indications and limitations of the techniques based on stone size and burden

Understand the different products used for percutaneous and ureteroscopic procedures including access, dilation, stone fragmentation and stone removal

Learn how properly evaluate and treat patient with endourologic surgeries

Methods: Update in different topics of Endourology will be discussed in this joint session. Emphasis will be placed on the indications, limitations, advantages, and description of the different surgical techniques. Faculty will share tips on their surgical techniques as well as tricks for a successful outcome with endourology procedures.

 

0630-0640

Is Mini-Perc the Current New Standard for PCNL?

 

 

Yes

 

Mahesh R. Desai, India

 

No

 

Amy Krambeck, United States

 

0640-0650

Laser Lithotripsy

 

 

Holmium YAG Laser

 

Anthony C.F. Ng, Hong Kong

 

Super Thulium Laser Fiber

 

Jorge Gutierrez, United States

 

0730-0830

 

IC-07: Instructional Course 07 - The Many Phenotypes of Neurogenic Bladder

 

Co-Chairs: John Stoffel, United States / Blayne Welk, Canada

To view this session in your own timezone, please click here.

 

 

Learning Objectives:

 

At the end of this session, attendees will be able to:

 

Describe the many causes of neuogenic bladder

Detail the various clinical presentation of lower urinary tract symptoms and corresponding urodynamic findings of neurogenic bladder

Connect the causes, clinical presentation and management into phenotypic groups

 

0730-0740

Introduction: Welcome and Brief Review of Etiology and Burden of Neurogenic Bladder Dysfunction, Key History/Physical Exam Tips

Co-Chair: John Stoffel, United States

 

0740-0825

Real World Management of Neurourology Cases and Interactive Case Discussion

 

 

A C6 SCI Patient Who Is Struggling with CIC: Ways to Improve CIC Performance/Adherence and Maximize QOL

 

Humphrey Atiemo, United States

 

An MS Patient Needing Help Managing SP Catheter Complications

 

Sara Lenherr, United States

 

Conclusion

Co-Chair: Blayne Welk, Canada

 

0810-0825

A Spina Bifida Patient with Incontinence and Hydro: What Surgical Options to Offer: Diversion/Augment/Type of Catheterization Channel

Faculty: Sean P. Elliott, United States

 

0830-0930

 

IC-08: Instructional Course 08 - Urologic Endoscopy in Resource Restricted Environments

 

Chair: Kymora Scotland, United States

 

 

Learning Objectives:

 

At the end of this session, attendees will be able to:

 

Learn to define optimal use of instruments in challenging environments

Understand and compare cost saving practices

Define and recognize risk from cost saving practices

Learn of innovations aimed at improving cost saving measures

 

0830-0835

Introduction and Outline of Objectives. Discussion of Disposables,

Kymora Scotland, United States

 

0835-0840

The Case for Minimally Invasive Surgery

Cyril Kamadjou, Cameroon

 

0840-0855

Endourology: Advice from the Egyptian Experience

Ehab Tawfiek, Egypt

 

0855-0920

Tips and Tricks In Endourology

Mohammed Lezrek, Morocco

 

0920-0930

The Sri Lankan Magic Box for Endourology Training

 

Srinath Chandrasekera, Sri Lanka

 

0830-0930

 

IC-09: Instructional Course 09 - E-Health, Digital Health, Telemedicine: Teleurology 101 — Getting Connected

 

Co-Chairs: Emmanuel Abara, Canada / Michael Borofsky, United States

To view this session in your own timezone, please click here.

 

 

Learning Objectives:

 

At the end of this session, attendees will be able to:

 

Define the terms e-Health, Digital Health, Telemedicine, and list various services that can be provided in Adult and Pediatric Urology.

Demonstrate knowledge of Delivery Models of e-Health, Teleurology/Telemedicine systems, procedures, EMRs, and some technical arrangements, e.g. Video-conferencing, e-Consult, Health Informatics; and ‘up and coming’ Artificial Intelligence (AI) and Robotics in Health Care.

Understand the Regulatory and Medico-legal considerations surrounding the provision of e-health, Telemedicine, etc. in various parts of the world

List various models available for re-imbursement of services as applicable to various jurisdictions; explore opportunities for using digital technology for delivery of urological education and care in the developing world

Determine one type of Teleurology service to focus on developing/adopting within 5 years from the end of this course, i.e., 2025.

 

0930-0950

 

02: Keynote Speaker

 

 

Deep Learning for Healthcare

Yoshua Bengio, Canada

 

1000-1045

 

INN: SIU Innovators Symposium - Prostate Cancer Debate

 

Chair: Ashish M. Kamat, United States

Co-Chairs: Dean Elterman, Canada / Imogen Patterson, Australia

 

 

Prostate Cancer Debate

 

a) Prostate cancer in the elderly

 

At the conclusion of this activity, participants will be able to:

 

Select the correct therapeutic strategy for patients with localized prostate cancer, depending on different patient and tumor characteristics.

List the advantages and disadvantages of prostate biopsy strategies

b) PSMA and lymph nodes in prostate cancer

 

At the conclusion of this activity, participants will be able to:

 

Select the correct therapeutic strategy for patients with localized prostate cancer, depending on different patient and tumor characteristics.

List the advantages and disadvantages of prostate biopsy strategies

 

Prostate Cancer Debate

Moderator: Siska van Bruwaene, Belgium

 

1000-1020

1. Case Presentation: Prostate Cancer in the Elderly

 

1000-1001

A. Case Presentation: To Biopsy or not to Biopsy

Moderator: Siska van Bruwaene, Belgium

 

1001-1004

PRO

Brian F Chapin, United States

 

1004-1007

CON

Laurence Klotz, Canada

 

1007-1008

B. Case Presentation: Surgery versus Radiotherapy

Moderator: Siska van Bruwaene, Belgium

 

1008-1011

PRO

Shusuke Akamatsu, Japan

 

1011-1014

CON

Andrés Hernández-Porras, Mexico

 

1014-1020

Discussion

 

Moderator: Siska van Bruwaene, Belgium

Shusuke Akamatsu, Japan

Andrés Hernández-Porras, Mexico

Laurence Klotz, Canada

 

1025-1045

2. Case Discussion: PSMA and Lymph Nodes in Prostate Cancer

 

1025-1026

Case Presentation

Moderator: Siska van Bruwaene, Belgium

 

1026-1030

No Lymph Node Dissection. No PSMA.

Wouter Everaerts, Belgium

 

1030-1034

Treatment Tailored by PSMA.

Renu Eapen, Australia

 

1034-1038

Perform Lymph Node Dissection

Karim Touijer, United States

 

1038-1045

Discussion

 

Moderator: Siska van Bruwaene, Belgium

Renu Eapen, Australia

Wouter Everaerts, Belgium

Karim Touijer, United States

 

1130-1150

 

JS-05: Joint SIU-Society of Urologic Robotic Surgeons (SURS) Session

 

Chair: Jihad Kaouk, United States

 

Learning Objectives

 

State what's new in Robotic Surgical treatment of Kidney, Prostate, and bladder Cancer

Recognize new emerging procedures in robotic surgery

Recall technical tips and tricks for current robotic procedures

 

1130-1132

Introduction

Jihad Kaouk, United States

 

1132-1138

Robotic Simple Prostatectomy

Ashok Hemal, United States

 

1138-1144

Robotic Radical Prostatectomy

Ashutosh Tewari, United States

 

1144-1150

New Robotic Approaches for Prostatectomy

Jihad Kaouk, United States

 

1300-1400

 

MC-05: Master Class 05 - Managing Lower Urinary Tract Dysfunction in Renal Transplantation

 

Co-Chairs: William Nahas, Brazil / Puneet Sindhwani, United States

To view this session in your own timezone, please click here.

 

1300-1302

Introduction

Co-Chair: Puneet Sindhwani, United States

 

1302-1316

Patient Presenting for Transplantation with Posterior Urethral Valve (PUV)/Prune Belly

William Nahas, Brazil

 

1316-1330

Hostile Neurogenic Bladder and Tubercular Bladder

Nasser Simforoosh, IR Iran

 

1330-1344

Managing Recurrent UTIs: Pre and Post Transplantation

Ahmed El-Zawahry, United States

 

1344-1358

Managing Bladder Outlet Obstruction due to BPH : Pre and Post Transplantation

Puneet Sindhwani, United States

 

1358-1400

Closing Remarks

Co-Chair: William Nahas, Brazil

 

1400-1530

 

IC-17: Instructional Course 17 - A Multidisciplinary Team Approach to the Treatment of Urothelial Carcinoma in the age of anti-PD1 agents

 

Chair: Shaheen Alanee, United States

To view this session in your own timezone, please click here.

 

 

Learning Objectives:

 

At the end of this session, attendees will be able to:

 

Recognize the role of the multidisciplinary team (MDT) approach in the patient journey through treatment with immunotherapy for advanced bladder cancer

Receive an introduction to systemic Immunotherapy in bladder cancer

Recall the role of the MDT in identifying and managing immune-related side effects associated with anti-PD1 agents

Explain the Importance of interdisciplinary communication and education in preventing life-threatening complications

 

1400-1405

Course Introduction

Shaheen Alanee, United States

 

1405-1425

Background on Bladder Cancer and Introduction to Anti-PD1 Agents

Shaheen Alanee, United States

 

1425-1505

Benefits of MDT Approach for Patients Receiving Treatment with Anti PD Agents, and the Role of Anti-PD1 Agents in the Management of Locally Advanced and Metastatic Bladder Cancer

Petros Grivas, United States

 

1505-1530

Discussion

Shaheen Alanee, United States

 

1530-1550

 

PL-00: Closing Message

Honorary Chair: Jean de la Rosette, Turkey

 

David Castro-Díaz, Stavros Charalampous, Rajeev TP, Madhu S Agrawal, Kim Mammen, Matthew Cooperberg, Ghulam Nabi, Christopher Evans, Morgan Roupret, Surena Matin, Amlesh Seth, Nicola Nicolai, Curtis Pettaway, Satoshi Takahashi, Koichiro Wada, Mohamed El-Shazly, Sanjay Kulkarni, Mahesh R. Desai, Jorge Gutierrez, John Stoffel, Blayne Welk, Kymora Scotland, Emmanuel Abara, Michael Borofsky, Ashish M. Kamat, Dean Elterman, Imogen Patterson, Jihad Kaouk, William Nahas, Puneet Sindhwani, Shaheen Alanee, Jean de la Rosette

JS-02: Joint SIU-International Continence Society (ICS) Session, SYMP-07: Indian Urology Symposium, MC-04: Master Class 04 - Establishing Standardized Outcome Reporting in Your Urology Practice, JS-03: SIU-Society of Urologic Oncology (SUO)/EAU Section of Oncological Urology (ESOU) Session, CO-02: Controversies in Urology 02 - Controversies in the Management of Kidney Cancer, IS-02: Interactive Session 02 - Management of Penile Cancer including Organ-Sparing Approaches, IC-04: Instructional Course 04 - The Current Situation of Antimicrobial-Resistant Pathogens In Urological Fields, IC-05: Instructional Course 05 - Metabolic Work Up and Medical Treatment of Stones, IC-06: Instructional Course 06 - Urethral Stricture Surgery, JS-04: Joint SIU-Endourology Session, IC-07: Instructional Course 07 - The Many Phenotypes of Neurogenic Bladder, IC-08: Instructional Course 08 - Urologic Endoscopy in Resource Restricted Environments, IC-09: Instructional Course 09 - E-Health, Digital Health, Telemedicine: Teleurology 101 — Getting Connected, 02: Keynote Speaker, INN: SIU Innovators Symposium - Prostate Cancer Debate, JS-05: Joint SIU-Society of Urologic Robotic Surgeons (SURS) Session, MC-05: Master Class 05 - Managing Lower Urinary Tract Dysfunction in Renal Transplantation, IC-17: Instructional Course 17 - A Multidisciplinary Team Approach to the Treatment of Urothelial Carcinoma in the age of anti-PD1 agents, PL-00: Closing Message

Inglês

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES
 

Speakers

Helen O'Connell, Adrian Wagg, Chiruvella Mallikarjuna, Anant Kumar, Rajeev Sood, Sudhir Rawal, Ravindra Sabnis, Rajeev TP, Ghulam Nabi, Matthew Cooperberg, Sigrid V. Carlsson, Monique J. Roobol, Chandra Shekhar Biyani, Faiz Mumtaz, Christopher Evans, Morgan Roupret, Axel Bex, Jose Karam, Surena Matin, Amlesh Seth, Pierre Blanchard, Steve Nicholson, Nicola Nicolai, Curtis Pettaway, Philippe Spiess, Hiroshi Kiyota, Koichiro Wada, Satoshi Takahashi, Mohamed El-Shazly, Noor Buchholz, Ahmed El-Nahas, Guido Barbagli, Anthony Mundy, Sanjay Kulkarni, Mahesh R. Desai, Amy Krambeck, Anthony C.F. Ng, Jorge Gutierrez, Humphrey Atiemo, Sara Lenherr, Sean P. Elliott, Kymora Scotland, Cyril Kamadjou, Ehab Tawfiek, Mohammed Lezrek, Srinath Chandrasekera, Yoshua Bengio, Brian F Chapin, Laurence Klotz, Shusuke Akamatsu, Andrés Hernández-Porras, Wouter Everaerts, Renu Eapen, Karim Touijer, Jihad Kaouk, Ashok Hemal, Ashutosh Tewari, William Nahas, Nasser Simforoosh, Ahmed El-Zawahry, Puneet Sindhwani, Shaheen Alanee, Petros Grivas

 

Link to the Event

Banner to the Event

40th Congress of the Société Internationale d'Urologie
 
 
 

Download the Agenda

Search for our next event. See you soon!

Subscribe to get news on all upcoming events

who%20goals_edited.png

DocMeeetings

Social Media

  • Twitter DocMeetings
  • Instagram DocMeetings
  • Facebook ícone social
  • LinkedIn ícone social

contact us

Adress

Sao Paulo, SP - Brazil

© 2020 by Docmeetings - A DocMeetings.com Company
Site Managed by:
QUALITY Soluções Web
1996-2021 "25 years inspiring technology"